Global Non-Hodgkin's Lymphoma Drug Supply, Demand and Key Producers, 2024-2030

Description

The global Non-Hodgkin's Lymphoma Drug market size is expected to reach $ 12940 million by 2030, rising at a market growth of 6.9% CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Non-Hodgkin's lymphoma is a type of cancer that begins in your lymphatic system, which is part of the body's germ-fighting immune system. In non-Hodgkin's lymphoma, white blood cells called lymphocytes grow abnormally and can form growths (tumors) throughout the body.

This report studies the global Non-Hodgkin's Lymphoma Drug demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Non-Hodgkin's Lymphoma Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Non-Hodgkin's Lymphoma Drug that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Non-Hodgkin's Lymphoma Drug total market, 2019-2030, (USD Million)
Global Non-Hodgkin's Lymphoma Drug total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Non-Hodgkin's Lymphoma Drug total market, key domestic companies and share, (USD Million)
Global Non-Hodgkin's Lymphoma Drug revenue by player and market share 2019-2024, (USD Million)
Global Non-Hodgkin's Lymphoma Drug total market by Type, CAGR, 2019-2030, (USD Million)
Global Non-Hodgkin's Lymphoma Drug total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Non-Hodgkin's Lymphoma Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Gilead Sciences, TG Therapeutics, Bayer, Secura Bio, Epizyme, Eisai, Acrotech Biopharma and Teva, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Non-Hodgkin's Lymphoma Drug market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Non-Hodgkin's Lymphoma Drug Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Non-Hodgkin's Lymphoma Drug Market, Segmentation by Type
    Oral
    Injection

Global Non-Hodgkin's Lymphoma Drug Market, Segmentation by Application
    Hospital
    Retail Pharmacy
    Other

Companies Profiled:
    Roche
    Gilead Sciences
    TG Therapeutics
    Bayer
    Secura Bio
    Epizyme
    Eisai
    Acrotech Biopharma
    Teva
    Eagle Pharmaceuticals
    MundiPharma

Key Questions Answered
1. How big is the global Non-Hodgkin's Lymphoma Drug market?
2. What is the demand of the global Non-Hodgkin's Lymphoma Drug market?
3. What is the year over year growth of the global Non-Hodgkin's Lymphoma Drug market?
4. What is the total value of the global Non-Hodgkin's Lymphoma Drug market?
5. Who are the major players in the global Non-Hodgkin's Lymphoma Drug market?

Table of Contents

1 Supply Summary
    1.1 Non-Hodgkin's Lymphoma Drug Introduction
    1.2 World Non-Hodgkin's Lymphoma Drug Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Non-Hodgkin's Lymphoma Drug Total Market by Region (by Headquarter Location)
        1.3.1 World Non-Hodgkin's Lymphoma Drug Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Non-Hodgkin's Lymphoma Drug Market Size (2019-2030)
        1.3.3 China Non-Hodgkin's Lymphoma Drug Market Size (2019-2030)
        1.3.4 Europe Non-Hodgkin's Lymphoma Drug Market Size (2019-2030)
        1.3.5 Japan Non-Hodgkin's Lymphoma Drug Market Size (2019-2030)
        1.3.6 South Korea Non-Hodgkin's Lymphoma Drug Market Size (2019-2030)
        1.3.7 ASEAN Non-Hodgkin's Lymphoma Drug Market Size (2019-2030)
        1.3.8 India Non-Hodgkin's Lymphoma Drug Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Non-Hodgkin's Lymphoma Drug Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Non-Hodgkin's Lymphoma Drug Major Market Trends

2 Demand Summary
    2.1 World Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030)
    2.2 World Non-Hodgkin's Lymphoma Drug Consumption Value by Region
        2.2.1 World Non-Hodgkin's Lymphoma Drug Consumption Value by Region (2019-2024)
        2.2.2 World Non-Hodgkin's Lymphoma Drug Consumption Value Forecast by Region (2025-2030)
    2.3 United States Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030)
    2.4 China Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030)
    2.5 Europe Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030)
    2.6 Japan Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030)
    2.7 South Korea Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030)
    2.8 ASEAN Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030)
    2.9 India Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030)

3 World Non-Hodgkin's Lymphoma Drug Companies Competitive Analysis
    3.1 World Non-Hodgkin's Lymphoma Drug Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Non-Hodgkin's Lymphoma Drug Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Non-Hodgkin's Lymphoma Drug in 2023
        3.2.3 Global Concentration Ratios (CR8) for Non-Hodgkin's Lymphoma Drug in 2023
    3.3 Non-Hodgkin's Lymphoma Drug Company Evaluation Quadrant
    3.4 Non-Hodgkin's Lymphoma Drug Market: Overall Company Footprint Analysis
        3.4.1 Non-Hodgkin's Lymphoma Drug Market: Region Footprint
        3.4.2 Non-Hodgkin's Lymphoma Drug Market: Company Product Type Footprint
        3.4.3 Non-Hodgkin's Lymphoma Drug Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Non-Hodgkin's Lymphoma Drug Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Non-Hodgkin's Lymphoma Drug Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Non-Hodgkin's Lymphoma Drug Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Non-Hodgkin's Lymphoma Drug Consumption Value Comparison
        4.2.1 United States VS China: Non-Hodgkin's Lymphoma Drug Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Non-Hodgkin's Lymphoma Drug Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Non-Hodgkin's Lymphoma Drug Companies and Market Share, 2019-2024
        4.3.1 United States Based Non-Hodgkin's Lymphoma Drug Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Non-Hodgkin's Lymphoma Drug Revenue, (2019-2024)
    4.4 China Based Companies Non-Hodgkin's Lymphoma Drug Revenue and Market Share, 2019-2024
        4.4.1 China Based Non-Hodgkin's Lymphoma Drug Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Non-Hodgkin's Lymphoma Drug Revenue, (2019-2024)
    4.5 Rest of World Based Non-Hodgkin's Lymphoma Drug Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Non-Hodgkin's Lymphoma Drug Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Non-Hodgkin's Lymphoma Drug Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Non-Hodgkin's Lymphoma Drug Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Oral
        5.2.2 Injection
    5.3 Market Segment by Type
        5.3.1 World Non-Hodgkin's Lymphoma Drug Market Size by Type (2019-2024)
        5.3.2 World Non-Hodgkin's Lymphoma Drug Market Size by Type (2025-2030)
        5.3.3 World Non-Hodgkin's Lymphoma Drug Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Non-Hodgkin's Lymphoma Drug Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Retail Pharmacy
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Non-Hodgkin's Lymphoma Drug Market Size by Application (2019-2024)
        6.3.2 World Non-Hodgkin's Lymphoma Drug Market Size by Application (2025-2030)
        6.3.3 World Non-Hodgkin's Lymphoma Drug Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Roche
        7.1.1 Roche Details
        7.1.2 Roche Major Business
        7.1.3 Roche Non-Hodgkin's Lymphoma Drug Product and Services
        7.1.4 Roche Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Roche Recent Developments/Updates
        7.1.6 Roche Competitive Strengths & Weaknesses
    7.2 Gilead Sciences
        7.2.1 Gilead Sciences Details
        7.2.2 Gilead Sciences Major Business
        7.2.3 Gilead Sciences Non-Hodgkin's Lymphoma Drug Product and Services
        7.2.4 Gilead Sciences Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Gilead Sciences Recent Developments/Updates
        7.2.6 Gilead Sciences Competitive Strengths & Weaknesses
    7.3 TG Therapeutics
        7.3.1 TG Therapeutics Details
        7.3.2 TG Therapeutics Major Business
        7.3.3 TG Therapeutics Non-Hodgkin's Lymphoma Drug Product and Services
        7.3.4 TG Therapeutics Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 TG Therapeutics Recent Developments/Updates
        7.3.6 TG Therapeutics Competitive Strengths & Weaknesses
    7.4 Bayer
        7.4.1 Bayer Details
        7.4.2 Bayer Major Business
        7.4.3 Bayer Non-Hodgkin's Lymphoma Drug Product and Services
        7.4.4 Bayer Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Bayer Recent Developments/Updates
        7.4.6 Bayer Competitive Strengths & Weaknesses
    7.5 Secura Bio
        7.5.1 Secura Bio Details
        7.5.2 Secura Bio Major Business
        7.5.3 Secura Bio Non-Hodgkin's Lymphoma Drug Product and Services
        7.5.4 Secura Bio Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Secura Bio Recent Developments/Updates
        7.5.6 Secura Bio Competitive Strengths & Weaknesses
    7.6 Epizyme
        7.6.1 Epizyme Details
        7.6.2 Epizyme Major Business
        7.6.3 Epizyme Non-Hodgkin's Lymphoma Drug Product and Services
        7.6.4 Epizyme Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Epizyme Recent Developments/Updates
        7.6.6 Epizyme Competitive Strengths & Weaknesses
    7.7 Eisai
        7.7.1 Eisai Details
        7.7.2 Eisai Major Business
        7.7.3 Eisai Non-Hodgkin's Lymphoma Drug Product and Services
        7.7.4 Eisai Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Eisai Recent Developments/Updates
        7.7.6 Eisai Competitive Strengths & Weaknesses
    7.8 Acrotech Biopharma
        7.8.1 Acrotech Biopharma Details
        7.8.2 Acrotech Biopharma Major Business
        7.8.3 Acrotech Biopharma Non-Hodgkin's Lymphoma Drug Product and Services
        7.8.4 Acrotech Biopharma Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Acrotech Biopharma Recent Developments/Updates
        7.8.6 Acrotech Biopharma Competitive Strengths & Weaknesses
    7.9 Teva
        7.9.1 Teva Details
        7.9.2 Teva Major Business
        7.9.3 Teva Non-Hodgkin's Lymphoma Drug Product and Services
        7.9.4 Teva Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Teva Recent Developments/Updates
        7.9.6 Teva Competitive Strengths & Weaknesses
    7.10 Eagle Pharmaceuticals
        7.10.1 Eagle Pharmaceuticals Details
        7.10.2 Eagle Pharmaceuticals Major Business
        7.10.3 Eagle Pharmaceuticals Non-Hodgkin's Lymphoma Drug Product and Services
        7.10.4 Eagle Pharmaceuticals Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Eagle Pharmaceuticals Recent Developments/Updates
        7.10.6 Eagle Pharmaceuticals Competitive Strengths & Weaknesses
    7.11 MundiPharma
        7.11.1 MundiPharma Details
        7.11.2 MundiPharma Major Business
        7.11.3 MundiPharma Non-Hodgkin's Lymphoma Drug Product and Services
        7.11.4 MundiPharma Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 MundiPharma Recent Developments/Updates
        7.11.6 MundiPharma Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Non-Hodgkin's Lymphoma Drug Industry Chain
    8.2 Non-Hodgkin's Lymphoma Drug Upstream Analysis
    8.3 Non-Hodgkin's Lymphoma Drug Midstream Analysis
    8.4 Non-Hodgkin's Lymphoma Drug Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Non-Hodgkin's Lymphoma Drug Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Non-Hodgkin's Lymphoma Drug Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Non-Hodgkin's Lymphoma Drug Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Non-Hodgkin's Lymphoma Drug Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Non-Hodgkin's Lymphoma Drug Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Non-Hodgkin's Lymphoma Drug Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Non-Hodgkin's Lymphoma Drug Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Non-Hodgkin's Lymphoma Drug Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Non-Hodgkin's Lymphoma Drug Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Non-Hodgkin's Lymphoma Drug Players in 2023
    Table 12. World Non-Hodgkin's Lymphoma Drug Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Non-Hodgkin's Lymphoma Drug Company Evaluation Quadrant
    Table 14. Head Office of Key Non-Hodgkin's Lymphoma Drug Player
    Table 15. Non-Hodgkin's Lymphoma Drug Market: Company Product Type Footprint
    Table 16. Non-Hodgkin's Lymphoma Drug Market: Company Product Application Footprint
    Table 17. Non-Hodgkin's Lymphoma Drug Mergers & Acquisitions Activity
    Table 18. United States VS China Non-Hodgkin's Lymphoma Drug Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Non-Hodgkin's Lymphoma Drug Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Non-Hodgkin's Lymphoma Drug Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Non-Hodgkin's Lymphoma Drug Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Non-Hodgkin's Lymphoma Drug Revenue Market Share (2019-2024)
    Table 23. China Based Non-Hodgkin's Lymphoma Drug Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Non-Hodgkin's Lymphoma Drug Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Non-Hodgkin's Lymphoma Drug Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Non-Hodgkin's Lymphoma Drug Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Non-Hodgkin's Lymphoma Drug Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Non-Hodgkin's Lymphoma Drug Revenue Market Share (2019-2024)
    Table 29. World Non-Hodgkin's Lymphoma Drug Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Non-Hodgkin's Lymphoma Drug Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Non-Hodgkin's Lymphoma Drug Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Non-Hodgkin's Lymphoma Drug Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Non-Hodgkin's Lymphoma Drug Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Non-Hodgkin's Lymphoma Drug Market Size by Application (2025-2030) & (USD Million)
    Table 35. Roche Basic Information, Area Served and Competitors
    Table 36. Roche Major Business
    Table 37. Roche Non-Hodgkin's Lymphoma Drug Product and Services
    Table 38. Roche Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Roche Recent Developments/Updates
    Table 40. Roche Competitive Strengths & Weaknesses
    Table 41. Gilead Sciences Basic Information, Area Served and Competitors
    Table 42. Gilead Sciences Major Business
    Table 43. Gilead Sciences Non-Hodgkin's Lymphoma Drug Product and Services
    Table 44. Gilead Sciences Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Gilead Sciences Recent Developments/Updates
    Table 46. Gilead Sciences Competitive Strengths & Weaknesses
    Table 47. TG Therapeutics Basic Information, Area Served and Competitors
    Table 48. TG Therapeutics Major Business
    Table 49. TG Therapeutics Non-Hodgkin's Lymphoma Drug Product and Services
    Table 50. TG Therapeutics Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. TG Therapeutics Recent Developments/Updates
    Table 52. TG Therapeutics Competitive Strengths & Weaknesses
    Table 53. Bayer Basic Information, Area Served and Competitors
    Table 54. Bayer Major Business
    Table 55. Bayer Non-Hodgkin's Lymphoma Drug Product and Services
    Table 56. Bayer Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Bayer Recent Developments/Updates
    Table 58. Bayer Competitive Strengths & Weaknesses
    Table 59. Secura Bio Basic Information, Area Served and Competitors
    Table 60. Secura Bio Major Business
    Table 61. Secura Bio Non-Hodgkin's Lymphoma Drug Product and Services
    Table 62. Secura Bio Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Secura Bio Recent Developments/Updates
    Table 64. Secura Bio Competitive Strengths & Weaknesses
    Table 65. Epizyme Basic Information, Area Served and Competitors
    Table 66. Epizyme Major Business
    Table 67. Epizyme Non-Hodgkin's Lymphoma Drug Product and Services
    Table 68. Epizyme Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Epizyme Recent Developments/Updates
    Table 70. Epizyme Competitive Strengths & Weaknesses
    Table 71. Eisai Basic Information, Area Served and Competitors
    Table 72. Eisai Major Business
    Table 73. Eisai Non-Hodgkin's Lymphoma Drug Product and Services
    Table 74. Eisai Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Eisai Recent Developments/Updates
    Table 76. Eisai Competitive Strengths & Weaknesses
    Table 77. Acrotech Biopharma Basic Information, Area Served and Competitors
    Table 78. Acrotech Biopharma Major Business
    Table 79. Acrotech Biopharma Non-Hodgkin's Lymphoma Drug Product and Services
    Table 80. Acrotech Biopharma Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Acrotech Biopharma Recent Developments/Updates
    Table 82. Acrotech Biopharma Competitive Strengths & Weaknesses
    Table 83. Teva Basic Information, Area Served and Competitors
    Table 84. Teva Major Business
    Table 85. Teva Non-Hodgkin's Lymphoma Drug Product and Services
    Table 86. Teva Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. Teva Recent Developments/Updates
    Table 88. Teva Competitive Strengths & Weaknesses
    Table 89. Eagle Pharmaceuticals Basic Information, Area Served and Competitors
    Table 90. Eagle Pharmaceuticals Major Business
    Table 91. Eagle Pharmaceuticals Non-Hodgkin's Lymphoma Drug Product and Services
    Table 92. Eagle Pharmaceuticals Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. Eagle Pharmaceuticals Recent Developments/Updates
    Table 94. MundiPharma Basic Information, Area Served and Competitors
    Table 95. MundiPharma Major Business
    Table 96. MundiPharma Non-Hodgkin's Lymphoma Drug Product and Services
    Table 97. MundiPharma Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 98. Global Key Players of Non-Hodgkin's Lymphoma Drug Upstream (Raw Materials)
    Table 99. Non-Hodgkin's Lymphoma Drug Typical Customers
List of Figure
    Figure 1. Non-Hodgkin's Lymphoma Drug Picture
    Figure 2. World Non-Hodgkin's Lymphoma Drug Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Non-Hodgkin's Lymphoma Drug Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Non-Hodgkin's Lymphoma Drug Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Non-Hodgkin's Lymphoma Drug Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Non-Hodgkin's Lymphoma Drug Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Non-Hodgkin's Lymphoma Drug Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Non-Hodgkin's Lymphoma Drug Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Non-Hodgkin's Lymphoma Drug Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Non-Hodgkin's Lymphoma Drug Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Non-Hodgkin's Lymphoma Drug Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Non-Hodgkin's Lymphoma Drug Revenue (2019-2030) & (USD Million)
    Figure 13. Non-Hodgkin's Lymphoma Drug Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Non-Hodgkin's Lymphoma Drug Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Non-Hodgkin's Lymphoma Drug by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Non-Hodgkin's Lymphoma Drug Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Non-Hodgkin's Lymphoma Drug Markets in 2023
    Figure 27. United States VS China: Non-Hodgkin's Lymphoma Drug Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Non-Hodgkin's Lymphoma Drug Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Non-Hodgkin's Lymphoma Drug Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Non-Hodgkin's Lymphoma Drug Market Size Market Share by Type in 2023
    Figure 31. Oral
    Figure 32. Injection
    Figure 33. World Non-Hodgkin's Lymphoma Drug Market Size Market Share by Type (2019-2030)
    Figure 34. World Non-Hodgkin's Lymphoma Drug Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 35. World Non-Hodgkin's Lymphoma Drug Market Size Market Share by Application in 2023
    Figure 36. Hospital
    Figure 37. Retail Pharmacy
    Figure 38. Other
    Figure 39. Non-Hodgkin's Lymphoma Drug Industrial Chain
    Figure 40. Methodology
    Figure 41. Research Process and Data Source

Companies Mentioned

Roche
Gilead Sciences
TG Therapeutics
Bayer
Secura Bio
Epizyme
Eisai
Acrotech Biopharma
Teva
Eagle Pharmaceuticals
MundiPharma